Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety
Journal of Clinical Medicine · 09.10.2023 · 12 (19) · 6424
DOI: 10.3390/jcm12196424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.10.2023. Verfasst von Peter Schnuelle. Beteiligte Einrichtung: Center for Renal Diseases Weinheim, Academic Teaching Practice of the University Medical Center Mannheim, University of Heidelberg, D-69469 Weinheim,…. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Renal biopsies are the gold standard for diagnosis, staging, and prognosis of underlying parenchymal kidney disease. This article provides an overview of the current indications and highlights ways to reduce bleeding complications in order to achieve optimal diagnostic yield with minimal risk to the patient. Novel indications have emerged from the increasing use of new molecularly targeted oncologic therapies in recent years, which often induce immune-mediated renal disease. On the other hand, the detection of specific antibodies against target antigens on podocytes in the sera of patients with new-onset nephrotic syndrome has now relativized the indication for biopsy in membranous nephropathy. The use of semi-automatic spring-loaded biopsy devices and real-time ultrasound considerably declined the complication rate and is the current standard. Percutaneous renal biopsies are overall a safe procedure if contraindications are considered. A coagulation disorder needs to be excluded beforehand, and an elevated blood pressure must be reduced to the normotensive range with medications. A laparoscopic approach or a radiology interventional procedure through the internal jugular vein may be considered for obtaining a kidney tissue sample if there is an urgent indication and a bleeding tendency cannot be adequately corrected. Major bleeding after a percutaneous renal biopsy can usually be managed with selective arterial embolization of the injured renal vessel. The use of a 16-gauge needle is the most reasonable compromise between diagnostic benefit and risk of complication. In the routine diagnostic, the biopsy specimen is examined with light microscopy, immunohistochemistry, and electron microscopy. Combination with modern molecular pathology techniques will contribute to more precise insights into the development and progression of kidney disease, which will likely refine future treatments in nephrology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Renal Diseases Weinheim, Academic Teaching Practice of the University Medical Center Mannheim, University of Heidelberg, D-69469 Weinheim, Germany.
ORCID-Profile: Peter Schnuelle
Zitieren
APA
Schnuelle, P. (2023). Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety. Journal of Clinical Medicine, 12(19), 6424. https://doi.org/10.3390/jcm12196424
Vancouver
Schnuelle P. Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety. Journal of Clinical Medicine. 2023;12(19):6424. doi:10.3390/jcm12196424
BibTeX
@article{Schnuelle2023,
author = {Schnuelle, Peter},
title = {Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {19},
pages = {6424},
doi = {10.3390/jcm12196424}
}
EUVIMED